| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dagmar Verbaan, Stephanie M van Rooden, Jacobus J van Hilten, Roselyne M Rijsma. Prevalence and clinical profile of restless legs syndrome in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 13. 2011-01-26. PMID:20737549. |
parkinson's disease (pd) and restless legs syndrome (rls) have a dopaminergic link. |
2011-01-26 |
2023-08-12 |
Not clear |
| Diego García-Borreguero, Anne-Marie William. Dopaminergic augmentation of restless legs syndrome. Sleep medicine reviews. vol 14. issue 5. 2011-01-11. PMID:20219397. |
dopaminergic augmentation of restless legs syndrome. |
2011-01-11 |
2023-08-12 |
Not clear |
| Diego García-Borreguero, Anne-Marie William. Dopaminergic augmentation of restless legs syndrome. Sleep medicine reviews. vol 14. issue 5. 2011-01-11. PMID:20219397. |
dopaminergic agents are the first-line treatment of restless legs syndrome (rls), and have been used for the treatment of this disorder since the 1980s. |
2011-01-11 |
2023-08-12 |
Not clear |
| Jana Godau, Nike Spinnler, Anne-Kathrin Wevers, Claudia Trenkwalder, Daniela Ber. Poor effect of guideline based treatment of restless legs syndrome in clinical practice. Journal of neurology, neurosurgery, and psychiatry. vol 81. issue 12. 2010-12-20. PMID:20884674. |
numerous randomised controlled trials have proved the efficacy of dopaminergic and non-dopaminergic drugs in the treatment of restless legs syndrome (rls). |
2010-12-20 |
2023-08-12 |
Not clear |
| Susan Imamura, Clete Kushid. Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome. Expert opinion on pharmacotherapy. vol 11. issue 11. 2010-11-01. PMID:20629607. |
gabapentin enacarbil (xp13512/gsk1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome. |
2010-11-01 |
2023-08-12 |
Not clear |
| Susan Imamura, Clete Kushid. Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome. Expert opinion on pharmacotherapy. vol 11. issue 11. 2010-11-01. PMID:20629607. |
gabapentin enacarbil (xp13512/gsk1838262) is being explored as an alternative treatment for restless legs syndrome (rls), which currently relies heavily on dopaminergic agents; however, these latter medications have the reported complications of augmentation. |
2010-11-01 |
2023-08-12 |
Not clear |
| Drug-induced restless legs syndrome. Prescrire international. vol 19. issue 108. 2010-10-26. PMID:20939448. |
some drugs used to treat restless legs syndrome, especially dopaminergic drugs, can in fact aggravate symptoms. |
2010-10-26 |
2023-08-12 |
Not clear |
| b' C\\xc3\\xa9sar Quiroz, Virginia Pearson, Seema Gulyani, Richard Allen, Christopher Earley, Sergi Ferr\\xc3\\xa. Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission. Experimental neurology. vol 224. issue 1. 2010-06-28. PMID:20385128.' |
brain iron deficiency leads to altered dopaminergic function in experimental animals, which can provide a mechanistic explanation for iron deficiency-related human sensory-motor disorders, such as restless legs syndrome (rls). |
2010-06-28 |
2023-08-12 |
human |
| Anna Scalise, Italo Pittaro-Cadore, Francesco Janes, Roberto Marinig, Gian Luigi Gigl. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Sleep medicine. vol 11. issue 1. 2010-05-14. PMID:19595629. |
changes of cortical excitability after dopaminergic treatment in restless legs syndrome. |
2010-05-14 |
2023-08-12 |
Not clear |
| Anna Scalise, Italo Pittaro-Cadore, Francesco Janes, Roberto Marinig, Gian Luigi Gigl. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Sleep medicine. vol 11. issue 1. 2010-05-14. PMID:19595629. |
dopaminergic pathways are most likely involved in the pathophysiology of restless legs syndrome (rls). |
2010-05-14 |
2023-08-12 |
Not clear |
| Emmanuelle Pourcher, Sophie Rémillard, Henri Cohe. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. Journal of the neurological sciences. vol 290. issue 1-2. 2010-05-13. PMID:19969309. |
compulsive habits in restless legs syndrome patients under dopaminergic treatment. |
2010-05-13 |
2023-08-12 |
Not clear |
| V Mylius, J C Möller, K Strauch, W H Oertel, K Stiasny-Kolste. No significance of the COMT val158met polymorphism in restless legs syndrome. Neuroscience letters. vol 473. issue 2. 2010-04-08. PMID:20184941. |
recent investigations support the notion of an alteration of the medial pain pathway as well as of the descending inhibitory control system in restless legs syndrome (rls), that both involve dopaminergic transmission as well. |
2010-04-08 |
2023-08-12 |
Not clear |
| Xiang Gao, Michael A Schwarzschild, Eilis J O'Reilly, Hao Wang, Alberto Ascheri. Restless legs syndrome and erectile dysfunction. Sleep. vol 33. issue 1. 2010-03-08. PMID:20120623. |
dopaminergic hypofunction in the central nervous system may contribute to restless legs syndrome (rls) and erectile dysfunction (ed). |
2010-03-08 |
2023-08-12 |
Not clear |
| Jason R Cornelius, Maja Tippmann-Peikert, Nancy L Slocumb, Courtney F Frerichs, Michael H Silbe. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. vol 33. issue 1. 2010-03-08. PMID:20120624. |
impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. |
2010-03-08 |
2023-08-12 |
Not clear |
| Jason R Cornelius, Maja Tippmann-Peikert, Nancy L Slocumb, Courtney F Frerichs, Michael H Silbe. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. vol 33. issue 1. 2010-03-08. PMID:20120624. |
to determine the frequency of impulse control disorders (icds) with the use of dopaminergic agents in restless legs syndrome (rls). |
2010-03-08 |
2023-08-12 |
Not clear |
| Christopher J Earley, Richard P Allen, James R Connor, Luigi Ferrucci, Juan Troncos. The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal. Sleep medicine. vol 10. issue 10. 2010-02-24. PMID:19307154. |
although the positive clinical benefits of levodopa have fostered the concept of an abnormality in the dopaminergic system in restless legs syndrome (rls), research into the nigro-striatal (pet/spect studies) or tubero-infundibular (i.e., prolactin secretion) dopaminergic pathways has shown limited positive results. |
2010-02-24 |
2023-08-12 |
Not clear |
| Félix Javier Jiménez-Jiménez, Lluisa Rubio, Marisol Calleja, Hortensia Alonso-Navarro, Laura Turpín-Fenoll, José Francisco Plaza-Nieto, Belén Pilo-de-la-Fuente, Pedro J García-Ruiz, José A G Agúnde. Motor performance in patients with restless legs syndrome. Movement disorders : official journal of the Movement Disorder Society. vol 24. issue 11. 2010-01-15. PMID:19514052. |
dopaminergic dysfunction could play a role in restless legs syndrome, and patients with central dopaminergic dysfunction exhibit difficulties in performing alternating movements or in the movement initiation. |
2010-01-15 |
2023-08-12 |
Not clear |
| Arun V Krishnan, Matthew C Kierna. Neurological complications of chronic kidney disease. Nature reviews. Neurology. vol 5. issue 10. 2009-12-16. PMID:19724248. |
exercise training programs and carnitine supplementation might be beneficial for neuromuscular complications, and restless legs syndrome in ckd responds to dopaminergic agonists and levodopa treatment. |
2009-12-16 |
2023-08-12 |
Not clear |
| Ulf Kallweit, Massimiliano M Siccoli, Rositsa Poryazova, Esther Werth, Claudio L Bassett. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. European neurology. vol 62. issue 3. 2009-10-09. PMID:19602890. |
excessive daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. |
2009-10-09 |
2023-08-12 |
Not clear |
| Luis Jimenez-Trevin. Oxcarbazepine treatment of restless legs syndrome: three case reports. Clinical neuropharmacology. vol 32. issue 3. 2009-08-10. PMID:19483488. |
the 4 classes of medication most used for restless legs syndrome include dopaminergic agents, benzodiazepines, opioids, and anticonvulsants such as gabapentin or carbamazepine. |
2009-08-10 |
2023-08-12 |
Not clear |